Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn.
Zonare Medical Systems raised $34 million in equity funding earlier this month to put toward the development of a next-generation ultrasound platform. The company's Zone Sonography technology is being groomed first for general imaging and ob/gyn. Subsequent developments will address cardiology and 4D imaging. Previous and new investors include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, and Siemens Venture Capital.
The company is being directed by new president and CEO Donald J. Southard, who joined the firm last month after serving as president of Datascope's $160 million patient monitoring business.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.